Publications by authors named "P Lora Aprile"

Purpose: To assess and compare, through a retrospective cohort study, the relationships between frailty, comorbidity, multimorbidity, and levels of adherence to lipid-lowering drugs (LLDs), antihypertensives and antidepressants.

Methods: In a primary care database, we selected a cohort of patients aged 60 or older on December 31, 2022. The date of the first prescription of the aforementioned medications was the study index date.

View Article and Find Full Text PDF

Background: The guideline was promoted by the Italian General Practitioners-Primary Care and Geriatrics Hospital-Community Societies and was carried out involving the National Institute of Health and an Expert Panel including representatives from 25 Scientific and Health-Professional Organizations. The aim of the Guideline was to develop evidence-based recommendations on the efficacy of CGA in older people across different clinical settings and the accuracy and utility of CGA-based tools to assess prognosis.

Methods: According to the methodological handbook of the Italian National System of Guidelines and NICE criteria (National Institute for Health and Care Excellence in England), the Guideline was produced based on the Grading of Recommendations Assessment, Development and Evaluation.

View Article and Find Full Text PDF

Purpose: This study explores correlations of sarcopenia and its proxies, such as history of falls, asthenia, and ambulation issues, with frailty levels among older adults in primary care.

Methods: In a cohort of 546,590 patients aged 60 years or older, "definite" sarcopenia cases were operationally defined through the use of non-specific diagnostic codes coupled with inspection of free-texts. Proxies of sarcopenia, such as falls history, asthenia, and ambulation issues were considered as well.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on developing pullulan and dextran-based membranes for guided bone regeneration (GBR) in oral surgery, testing their potential as barrier membranes.
  • Two types of these membranes, one with hydroxyapatite (HA) and one without, were evaluated for their cytotoxicity and biocompatibility using human stem cells and a rat model.
  • Results showed that the HA-containing membrane significantly enhanced bone formation compared to a commercial collagen membrane, indicating its promise for improving GBR outcomes.
View Article and Find Full Text PDF